Human CD38: a (r)evolutionary story of enzymes and receptors
- 20 December 2000
- journal article
- review article
- Published by Elsevier BV in Leukemia Research
- Vol. 25 (1), 1-12
- https://doi.org/10.1016/s0145-2126(00)00093-x
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- The Immunological Synapse: A Molecular Machine Controlling T Cell ActivationScience, 1999
- Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic TrioxideNew England Journal of Medicine, 1998
- Molecular Mechanism of Human CD38 Gene Expression by Retinoic AcidPublished by Elsevier BV ,1998
- Human BST-1 Expressed on Myeloid Cells Functions as a Receptor MoleculeBiochemical and Biophysical Research Communications, 1996
- Pancreatic Islet Cells Express BST-1, a CD38-like Surface Molecule Having ADP-Ribosyl Cyclase ActivityBiochemical and Biophysical Research Communications, 1996
- Human CD38: a glycoprotein in search of a functionImmunology Today, 1994
- A Single Protein Immunologically Identified as CD38 Displays NAD+ Glycohydrolase, ADP-Ribosyl Cyclase and Cyclic ADP-Ribose Hydrolase Activities at the Outer Surface of Human ErythrocytesBiochemical and Biophysical Research Communications, 1993
- Characterization of a murine monoclonal antibody specific for human early lymphohemopoietic cellsHuman Immunology, 1984
- Chromosome assignment of monoclonal antibody‐defined determinants on human leukemic cellsEuropean Journal of Immunology, 1983
- Comparative expression of T9, T10, and Ia antigens on activated human T cell subsetsHuman Immunology, 1981